What is the step-by-step journey of a clinical trial?

The path, from start to finish

It helps to see the whole journey before you take the first step. A clinical trial is not one big decision made all at once. It is a series of smaller steps, and you have a choice at each one. Here is the path most people follow, in order.

You do not need to memorize this. Think of it as a map you can glance at, so you always know roughly where you are and what comes next.

Finding a trial and pre-screening

The journey starts by finding a trial that might match your situation. Your doctor may suggest one, or you may find one yourself and bring it to your care team.

Next comes pre-screening. This is a quick, early check of the basics, often a short phone call or a few questions. It looks at things like your cancer type, its stage, and treatments you have already had, to see if it is worth taking a closer look. Pre-screening saves you time. If a trial clearly is not a fit, you find that out early, before any tests.

Informed consent and screening

If pre-screening looks promising, the next step is informed consent.

This is a careful conversation where the research team walks you through the trial in full: what it is testing, what will happen, the possible benefits and risks, and your rights. You can ask anything and take your time. Only after you understand and agree do you sign the consent form. Consent always comes before any trial tests.

After you consent, screening begins. These are tests and exams, such as blood work or scans, that confirm you meet the trial’s eligibility criteria and can take part safely.

Enrollment and the treatment period

If your screening results confirm you qualify, you enroll. This is the point where you officially join the trial and your participation begins.

Then comes the treatment and monitoring period, the main part of the journey. You receive the trial’s approach, whether that is a medicine, a procedure, or another kind of care. Alongside it, the team watches your health closely with regular visits, tests, and check-ins, often more often than usual care. This is where the extra monitoring of a trial really shows up.

Follow-up, and then

After the treatment period ends, most trials include a stretch of follow-up. The team keeps in touch to see how you are doing over time. Follow-up visits are usually less frequent, and they help researchers learn how well the approach worked and how people do afterward.

That is the full arc: find, pre-screen, consent, screen, enroll, treatment, follow-up. Each step has a clear purpose, and you are never locked in. Understanding the shape of the journey is enough for now. The next lessons walk through the most important stops in more detail, starting with the conversation that protects you most: informed consent.